Clinical Trials
29 trialsA Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer
IRCCS San Raffaele
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
National Institutes of Health Clinical Center (CC)
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
National Institutes of Health Clinical Center (CC)
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
National Institutes of Health Clinical Center (CC)
DESCENT-1
A2 Biotherapeutics Inc.
LEARN
University of Sydney
KCC-S
University of Utah
Study of Kidney Tumors in Younger Patients
Children's Oncology Group
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Istituto Oncologico Veneto IRCCS
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
University Health Network, Toronto
iCaRe2
University of Nebraska
TDM for Optimized Outcome in Patients With mRCC.
University of Aarhus
BASECAMP-1
A2 Biotherapeutics Inc.
ELEPHAS-02
Elephas
FRISC
Centre Hospitalier Universitaire, Amiens
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
National Institutes of Health Clinical Center (CC)
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
National Institutes of Health Clinical Center (CC)
BIOSUNTOX
University Hospital, Rouen
RCCETT
Peking University Third Hospital
Risk of Scrotal Hydroceles After Nephrectomy For Kidney Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
SMART
University of Alberta
Kidney Cancer DNA Registry
Memorial Sloan Kettering Cancer Center
NEPHRAMBU
GCS Ramsay Santé pour l'Enseignement et la Recherche
PP-RECURK
Gødstrup Hospital
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Tel-Aviv Sourasky Medical Center
KIDCaD
Charles University, Czech Republic
SPECT/CT for the Characterization of Renal Masses
Jonsson Comprehensive Cancer Center
DISSRM
Abramson Cancer Center at Penn Medicine
OCCURORTW
Jagiellonian University